Kathryn E. Gropp

Kathryn E. Gropp

Auto-generated profile, based on publicly available information

Kathryn E. Gropp

Drug Safety Research and Development, Pfizer Inc., Groton, Connecticut, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2018 in Toxicologic Pathology
Verified
Journal Article
Closed access
KGKathryn E. Gropp
Kathryn E. Gropp
CCCathy S. Carlson
Cathy S. Carlson
MEMark G. Evans
Mark G. Evans
CBCedo M. Bagi
Cedo M. Bagi
WRWilliam J. Reagan
William J. Reagan
MZMark A. Zorbas
Mark A. Zorbas
Tanezumab, an anti-nerve growth factor (NGF) antibody, is in development for management of chronic pain. During clinical trials of anti-NGF antibodies, some patients reported unexpected adverse events requiring total joint replacements, resulting in a partial clinical hold on all NGF inhibitors. Three nonclinical toxicology studies were conducted to evaluate the effects of tanezumab or the murine precursor muMab911 on selected bone and joint endpoints and biomarkers in cynomolgus monkeys, Sprague-Dawley rats, and C57BL/6 mice. Joint and bone endpoints included histology, immunohistochemistry, microcomputed tomography (mCT) imaging, and serum biomarkers of bone physiology. Responses of bone endpoints to tanezumab were evaluated in monkeys at 4 to 30 mg/kg/week for 26 weeks and in rats at 0.2 to 10 mg/kg twice weekly for 28 days. The effects of muMab911 at 10 mg/kg/week for 12 weeks on selected bone endpoints were determined in mice. Tanezumab and muMab911 had no adverse effects on any bone or joint parameter. There were no test article–related effects on bone or joint histology, immunohistochemistry, or structure. Reversible, higher osteocalcin concentrations occurred only in the rat study. No deleterious effects were observed in joints or bones in monkeys, rats, or mice administered high doses of tanezumab or muMab911.

15 October 2017 in Toxicologic Pathology
Verified
Journal Article
Closed access
KGKathryn E. Gropp
Kathryn E. Gropp
Evaluation of skeletal muscle frequently combines morphologic and morphometric techniques. As is the case with many organ systems, skeletal muscle has limited responses to insult or injury. Over the past several years, crucial interactions between skeletal muscle, bone, and the nervous system have been described. The aim of this lecture was to give attendees the necessary background information in basic skeletal muscle morphology, important species differences, introduction to skeletal muscle biomarkers, approaches to morphologic and morphometric evaluation, and examples of background findings and typical responses of skeletal muscle to insult or injury.

15 October 2017 in Toxicologic Pathology
Verified
Journal Article
Closed access
KGKathryn E. Gropp
Kathryn E. Gropp
Cancellous bone has high metabolic activity compared to many other bone compartments and can be affected not only by changes in physeal activity but also by perturbations in homeostasis caused by changes in physiology or on-target pharmacology. Examples of several types of resulting morphologic findings were presented; if known, the pathways causing morphologic changes were discussed.

2 December 2025
Verified
Book Chapter
Closed access
ABAgathe Bédard
Agathe Bédard
KGKathryn E. Gropp
Kathryn E. Gropp
RSRyan M. Schafbuch
Ryan M. Schafbuch
JVJohn L. Vahle
John L. Vahle

16 September 2022 in Toxicologic Pathology
Verified
Journal Article
Closed access
KGKathryn E. Gropp
Kathryn E. Gropp
During this presentation, a variety of class effects were reviewed by their differing effects on bone, including inhibition of endochondral ossification, inhibition of the growth hormone-insulin-like growth factor 1 axis, promotion of bone formation, inhibition of bone formation, abnormal bone formation, promotion of bone resorption, inhibition of bone resorption, and bone necrosis.

6 May 2025
Verified
Book Chapter
Closed access
PDF file
KGKathryn E. Gropp
Kathryn E. Gropp
ABAgathe Bédard
Agathe Bédard
SFStacey Fossey
Stacey Fossey
DHD. Greg Hall
D. Greg Hall
RSRyan M. Schafbuch
Ryan M. Schafbuch
The musculoskeletal system, composed of bones, joints, and muscles, is a dynamic and complex system responsible for locomotion, mechanical support, and protection from trauma for internal organs, hematopoiesis, calcium and inorganic phosphorus metabolism, and endocrine regulation. As teeth share with bone the specificity of being a mineralized and dynamic tissue, toxic changes are often commonly encountered in both tissues simultaneously. As such, functional anatomy and physiology, as well as induced and spontaneous lesions noted in musculoskeletal system and teeth, will be discussed together in this chapter. In addition, considerations for adversity determination and translatability of findings will be presented, to provide a reference for toxicopathologists and toxicologists. <!----> <!----> <!----> <!---->